Experts find improved glucose metabolism using subcutaneous insulin

06/9/2011 | HealthDay News

Continuous subcutaneous insulin infusion improved the fasting gluconeogenesis and glycogen cycling in patients with poorly controlled type 1 diabetes, a study in the journal Diabetes found. CSII-treated patients had 70% lower net hepatic glycogen synthesis and 42% higher endogenous glucose production than a control group.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA